Primeadvanced Surescan
Device Spinal Cord Neurostimulation
PDI 00643169109513
General payments
$8,934
Research payments
$314,120
Through program year 2025, $8,934 in general payments and $314,120 in research payments were reported against Primeadvanced Surescan (Spinal Cord Neurostimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,178 | 170 |
| 2024 | General | $716 | 14 |
| 2023 | General | $27 | 2 |
| 2022 | General | $12 | 1 |
| 2022 | Research | $314,120 | 79 |
Breakdown
The top 5 of 85 recipients; each share is of general payments naming this product in 2025.
The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
187 general · 79 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.